Savavet Ataxin (Enrofloxacin) Broad-Spectrum Antibacterial Chewable Tablets for Dogs & Cats (Pack of 10 Tablets)

Select Variant: 1

Description

Overcome challenging, deep-seated bacterial infections in companion animals with Savavet Ataxin Chewable Tablets (Pack of 10), available online at PetMitra. Bacterial pathogens frequently target the urinary tract, lower airways, dermis, and ears of dogs and cats. Complicated conditions—such as recurrent bacterial cystitis, infected bite wounds, severe purulent pyoderma, and chronic otitis—require an antibacterial agent that achieves bactericidal tissue concentrations quickly and penetrates cellular barriers effectively. Savavet Ataxin provides rapid, concentration-dependent bacterial eradication powered by veterinary Enrofloxacin: Direct Bacterial DNA Topoisomerase Inhibition: Enrofloxacin belongs to the fluoroquinolone class developed specifically for veterinary medicine. It directly inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, halting DNA supercoiling, transcription, and repair. This triggers rapid DNA fragmentation and bacterial cell lysis in both dividing and stationary phases. Broad-Spectrum Pathogen Clearance: Delivers bactericidal activity against susceptible gram-negative organisms (Escherichia coli, Klebsiella, Proteus mirabilis, Pseudomonas aeruginosa, Pasteurella multocida, Salmonella) and significant gram-positive pathogens (Staphylococcus pseudintermedius). Exceptional Tissue & Urinary Bioavailability: Enrofloxacin is rapidly absorbed and concentrated in critical organs. It reaches high levels in urine (ideal for treating stubborn UTIs), bronchial secretions, pulmonary alveolar macrophages, skin layers, and otic canals. Meaty-Flavored Chewable Formulation: Formulated with an appealing savory flavor to improve patient compliance, eliminating pill-swallowing struggles in dogs and cats. Scored for Easy Weight Titration: Center score lines allow veterinarians and pet parents to split tablets accurately to match exact body-weight requirements. Key Features Potent Veterinary Fluoroquinolone: Formulated with Enrofloxacin for rapid, concentration-dependent bactericidal action. Dual-Enzyme Inhibition: Halts bacterial DNA gyrase and topoisomerase IV to trigger complete bacterial cell lysis. High Urinary Concentration: Primary urinary excretion provides targeted clinical efficacy against canine and feline cystitis and UTIs. Deep Tissue Penetration: Reaches therapeutic concentrations in bronchial secretions, deep dermal layers, wounds, and ear canals. Meaty Flavor Matrix: High-palatability chewable tablet accepted easily by both dogs and cats. Dual-Species Versatility: Available in 50 mg (ideal for cats and small dogs) and 150 mg (ideal for medium and large canines). Scored for Accurate Dosing: Easily split along the score line to ensure exact weight-adjusted antibiotic therapy.